Document Detail


Relapses in multiple sclerosis are age- and time-dependent.
MedLine Citation:
PMID:  18535026     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: To examine the relative relapse-rate patterns over time in a relapsing multiple sclerosis (MS) cohort and to investigate potential predictors of relapse rates and periods of low-relapse activity. METHODS: This retrospective cohort study followed 2477 relapsing-remitting (RR) MS patients from onset to 1 July 2003. Annualised relapse rates were examined according to sex, age at onset, the patient's current age and disease duration. The relationship between relapse rates and baseline characteristics (sex, onset age and onset symptoms) were examined using Poisson regression. Time to the first 5 years relapse-free was examined using Kaplan-Meier survival analysis. RESULTS: The mean follow-up time (from onset of MS symptoms) was 20.6 years, during which time 11,722 post-onset relapses were recorded. The relapse rate decreased by 17% every 5 years (between years 5 to 30 post-onset), but this decline increased in magnitude with increasing onset age. Women and those with onset sensory symptoms exhibited a higher relapse rate (p< or =0.001). More than three-quarters of patients (1692/2189) experienced a 5-year relapse-free period during the RR phase. CONCLUSION: Relapse rates were age- and time-dependent. Our observations have clinical implications: 1) any drug able to modify relapse rates has the greatest potential for a population impact in patients <40 years old and within the first few demi-decades of disease; 2) continuation of drug beyond these times may be of limited value; 3) long-term follow-up studies must consider that relapse rates probably decline at different rates over time according to the patient's onset age; 4) a relapse-quiescent period in MS is not uncommon.
Authors:
H Tremlett; Y Zhao; J Joseph; V Devonshire;
Related Documents :
2227956 - Clinical and genetic heterogeneity in retinitis pigmentosa.
11229996 - Evidence of a cohort effect for age at onset of schizophrenia.
2960786 - Which factors influence age at onset and rate of progression in huntington's disease?
3652596 - The natural history of night terrors.
12670606 - Association of depression with peripheral leukocyte counts in epic-norfolk--role of sex...
16251776 - Coronary risk variables in young asymptomatic smokers.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-06-05
Journal Detail:
Title:  Journal of neurology, neurosurgery, and psychiatry     Volume:  79     ISSN:  1468-330X     ISO Abbreviation:  J. Neurol. Neurosurg. Psychiatr.     Publication Date:  2008 Dec 
Date Detail:
Created Date:  2008-11-17     Completed Date:  2009-01-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985191R     Medline TA:  J Neurol Neurosurg Psychiatry     Country:  England    
Other Details:
Languages:  eng     Pagination:  1368-74     Citation Subset:  IM    
Affiliation:
Department of Medicine (Neurology), rm S178, 2211 Wesbrook Mall, University of British Columbia, Vancouver BCV6T2B5, Canada. tremlett@interchange.ubc.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Age Factors
Cohort Studies
Disease-Free Survival
Female
Follow-Up Studies
Humans
Longitudinal Studies
Male
Middle Aged
Multiple Sclerosis, Relapsing-Remitting / diagnosis*,  therapy*
Recurrence
Retrospective Studies
Time Factors
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dipyridamole plus aspirin versus aspirin alone in secondary prevention after TIA or stroke: a meta-a...
Next Document:  Effectiveness of rehabilitation intervention in persons with multiple sclerosis: a randomised contro...